JSW
CLB icon

Journey Strategic Wealth’s Core Laboratories CLB Stock Holding History

Journey Strategic Wealth’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,600
Closed -$198K – 403
2024
Q1 		$198K Buy
+11,600
New +$182K 0.01% 291

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Journey Strategic Wealth's CLB Position: Q2 2024 in Review

Journey Strategic Wealth sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 11,600 shares — an estimated $198K sold.

Journey Strategic Wealth first reported a position in CLB in Q1 2024 and held it in 1 quarter. The position peaked at $198K in Q1 2024. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Journey Strategic Wealth reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Journey Strategic Wealth sold 11,600 Core Laboratories shares in Q2 2024, an estimated $198K.
  • Journey Strategic Wealth first reported a position in Core Laboratories in Q1 2024 and held it in 1 quarter.
  • Journey Strategic Wealth's Core Laboratories position peaked at $198K in Q1 2024.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Journey Strategic Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.